2020 | | A multicenter anaphylaxis registry in Korea: Clinical characteristics and acute treatment details from infants to older adults | 신유섭, 예영민, 이수영, 정경욱 |
2021 | | A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea | 예영민 |
2020 | | A Prospective Observation of Psychological Distress in Patients With Anaphylaxis | 예영민, 이영수, 장형윤 |
2021 | | A prospective study to compare clinical outcomes of allergic rhinitis between older and younger adults: A potential effect of depression in older patients | 박해심, 신유섭, 예영민, 이영수 |
2022 | | A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization | 예영민 |
2023 | | Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor | 강호철, 박해심, 신민경, 예영민, 조중현, 최보윤 |
2023 | | Association of eosinophil-derived neurotoxin levels with asthma control status in patients with aspirin-exacerbated respiratory disease | 박해심, 예영민 |
2023 | | Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice | 김승현, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2024 | | Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma | 박해심, 신유섭, 예영민 |
2020 | | Causes of food allergy according to age and severity: A recent 10-year retrospective study from a single tertiary hospital | 남동호, 박해심, 신유섭, 예영민, 이수영, 정경욱 |
2021 | | Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins | 예영민, 이영수, 장재혁 |
2021 | | Changes in type 2 biomarkers after anti-il5 treatment in patients with severe eosinophilic asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2019 | | Chlorpheniramine-induced anaphylaxis: Two case reports and a retrospective review of pharmacovigilance database | 예영민, 우성대, 이소희, 이영수 |
2023 | | Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry | 예영민 |
2021 | | Clinical characteristics and risk factors for cefaclor-induced immediate hypersensitivity: a retrospective observation at two university hospitals in Korea | 예영민, 우성대, 이영수 |
2021 | | Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2020 | | Common causes and characteristics of adverse drug reactions in older adults: a retrospective study | 예영민, 우성대, 이영수 |
2021 | | COVID-19 vaccine-associated anaphylaxis and allergic reactions: Consensus statements of the KAAACI urticaria/angioedema/anaphylaxis working group | 박해심, 예영민, 이수영 |
2024 | | CRUSE®-An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria | 예영민 |
2020 | | Definition, aims, and implementation of GA(2) LEN/HAEi Angioedema Centers of Reference and Excellence | 예영민 |
2020 | | Detection of circulating IgG autoantibody to FcepsilonRIalpha in sera from chronic spontaneous urticaria patients | 박해심, 예영민 |
2022 | | Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
2024 | | Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2019 | | Dimerized, Not Monomeric, Translationally Controlled Tumor Protein Induces Basophil Activation and Mast Cell Degranulation in Chronic Urticaria | 박해심, 예영민 |
2021 | | Distribution and quality of life in patients with primary immunodeficiency diseases in a cohort of Korean adults | 박해심, 예영민 |
2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
2020 | | Efficacy and Safety of a Pressurized Metered-Dose Inhaler in Older Asthmatics: Comparison to a Dry Powder Inhaler in a 12-Week Randomized Trial | 박주헌, 박해심, 신유섭, 예영민, 우성대, 이영수 |
2024 | | Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials | 예영민 |
2019 | | Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications | 김승현, 박해심, 신승수, 신유섭, 예영민, 이소희, 정윤정 |
2023 | | Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines | 박해심, 신유섭, 예영민 |
2020 | | Efficacy, Safety, and Immunomodulatory Effect of the Intramuscular Administration of Autologous Total Immunoglobulin G for Atopic Dermatitis: A Randomized Clinical Trial | 남동호, 박해심, 신유섭, 예영민 |
2021 | | Elevated MRGPRX2 levels related to disease severity in patients with chronic spontaneous urticaria | 예영민 |
2021 | | Erratum: Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Establishment of reference intervals of serum immunoglobulins in healthy korean adults | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2024 | | Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies | 예영민 |
2020 | | Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients | 박해심, 신승수, 예영민 |
2020 | | Health-Related Utility of EQ-5D in Korean Adults With Chronic Urticaria: Mapping From Urticaria Outcome Measures | 박해심, 신유섭, 예영민 |
2020 | | Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease | 박해심, 예영민 |
2019 | | Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study | 박해심, 신유섭, 예영민 |
2022 | | Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU) | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
2020 | | Increasing Prevalence and Mortality of Asthma With Age in Korea, 2002-2015: A Nationwide, Population-Based Study | 박해심, 예영민 |
2023 | | Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease | 박해심, 예영민 |
2020 | | Non-episodic Angioedema With Eosinophilia Successfully Treated With Reslizumab | 박해심, 예영민 |
2021 | | Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma | 박해심, 신유섭, 예영민, 최영우 |
2020 | | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea | 박해심, 신유섭, 예영민 |
2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2023 | | Real-World Disease Burden of Chronic Urticaria and Vaccine Hesitancy | 예영민 |
2021 | | Risk factors predicting Severe Asthma exacerbations in adult asthmatics: A real-world clinical evidence | 박해심, 신유섭, 예영민 |
2019 | | Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis | 남동호, 박해심, 신유섭, 예영민, 이소희 |
2024 | | Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study | 박해심, 예영민 |